Jannie Oosthuizen's Insider Trades & SAST Disclosures
Jannie Oosthuizen's most recent trade in Merck & Co Inc was a trade of 18,807 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 29, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jannie Oosthuizen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 18,807 | 18,807 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 4,132 | 4,132 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 84.09 per share. | 19 Feb 2025 | 8,500 | 30,705 (0%) | 0% | 84.1 | 714,745 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2025 | 13,002 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.28 per share. | 08 Feb 2025 | 13,002 | 45,609 (0%) | 0% | 87.3 | 1,134,815 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.28 per share. | 08 Feb 2025 | 6,404 | 39,205 (0%) | 0% | 87.3 | 558,941 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 8,664 | 32,607 (0%) | 0% | 97.9 | 848,552 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 912 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.51 per share. | 04 May 2024 | 912 | 24,270 (0%) | 0% | 127.5 | 116,289 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 127.51 per share. | 04 May 2024 | 450 | 23,820 (0%) | 0% | 127.5 | 57,380 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 20,508 | 20,508 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 127.18 per share. | 02 Feb 2024 | 18,959 | 23,327 (0%) | 0% | 127.2 | 2,411,111 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 7,119 | 14,240 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 02 Feb 2024 | 7,119 | 42,286 (0%) | 0% | 87.1 | 620,065 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 7,045 | 7,049 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Oosthuizen Jannie | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.73 per share. | 02 Feb 2024 | 7,045 | 35,167 (0%) | 0% | 73.7 | 519,428 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.36 per share. | 02 Feb 2024 | 6,773 | 28,122 (0%) | 0% | 75.4 | 510,413 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 6,773 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 3,133 | 21,349 (0%) | 0% | 119.4 | 374,174 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 102.38 per share. | 09 Nov 2023 | 2,081 | 18,190 (0%) | 0% | 102.4 | 213,061 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.82 per share. | 30 Oct 2023 | 915 | 20,722 (0%) | 0% | 102.8 | 94,080 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2023 | 915 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.82 per share. | 30 Oct 2023 | 451 | 20,271 (0%) | 0% | 102.8 | 46,372 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 907 | 912 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 118.22 per share. | 04 May 2023 | 907 | 20,206 (0%) | 0% | 118.2 | 107,226 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.22 per share. | 04 May 2023 | 447 | 19,759 (0%) | 0% | 118.2 | 52,844 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 20,747 | 20,747 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 866 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 115.47 per share. | 01 May 2023 | 866 | 19,726 (0%) | 0% | 115.5 | 99,997 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.47 per share. | 01 May 2023 | 427 | 19,299 (0%) | 0% | 115.5 | 49,306 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 2,091 | 18,821 (0%) | 0% | 109.9 | 229,759 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 103.21 per share. | 09 Nov 2022 | 1,795 | 16,730 (0%) | 0% | 103.2 | 185,262 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 99.47 per share. | 07 Nov 2022 | 45,561 | 18,525 (0%) | 0% | 99.5 | 4,531,980 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 17,455 | 43,501 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 17,455 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 14,703 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 14,703 | 26,046 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 13,540 | 57,041 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 13,540 | 6,773 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 7,045 | 14,094 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2022 | 7,045 | 64,086 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Sale of securities on an exchange or to another person at price $ 100.21 per share. | 28 Oct 2022 | 3,633 | 10,880 (0%) | 0% | 100.2 | 364,065 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 28 Oct 2022 | 913 | 11,793 (0%) | 0% | 100.8 | 92,003 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 913 | 915 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | President, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.77 per share. | 28 Oct 2022 | 450 | 11,343 (0%) | 0% | 100.8 | 45,347 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 21,359 | 21,359 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 907 | 1,819 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 907 | 14,960 (0%) | 0% | 87.1 | 79,000 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 14,434 (0%) | 0% | 87.6 | 67,753 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 447 | 14,513 (0%) | 0% | 87.1 | 38,934 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 381 | 14,053 (0%) | 0% | 87.7 | 33,395 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 866 | 14,088 (0%) | 0% | 88.7 | 76,806 | Common Stock |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 866 | 866 | - | - | Restricted Stock Unit | |
| Merck & Co Inc | Jannie Oosthuizen | SVP, U.S. Market | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 427 | 13,661 (0%) | 0% | 88.7 | 37,871 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges